Ownership

Matt Abernethy - Chief Financial Officer at Neurocrine Biosciences Inc

Insider Transactions and Holdings

Entity Type: Individual
Role: Chief Financial Officer
Stock Symbol: NBIX on Nasdaq
Industry: Biological Products, (No Diagnostic Substances)
All Insider Reports: All Insider Reports

Matt Abernethy - trading volume in the past year for Neurocrine Biosciences Inc

	Shares	%	Avg Price	Total $
Buys
Sells	-49.8K	100%	$140.60	-$7M
Net	-49.8K	-100%		-$7M

Holdings reported by Matt Abernethy for Neurocrine Biosciences Inc

Security	Num Shares	Value	Price $	Transaction Date	Ownership	Underlying Class	Underlying Amount
Common Stock	35.8K	$4.19M	$116.87	Feb 13, 2025	Direct
Restricted Stock Unit	6.73K	$795K	$118.28	Feb 13, 2025	Direct	Common Stock
Restricted Stock Unit	8.97K	$388K	$43.24	Feb 13, 2024	Direct	Common Stock
Non-Qualified Stock Option	0	$0	$73.60	Aug 13, 2024	Direct	Common Stock
Stock Option	45.5K			Feb 12, 2025	Direct	Common Stock
Stock Option	45.1K			Feb 13, 2024	Direct	Common Stock

Transactions reported by Matt Abernethy for Neurocrine Biosciences Inc

Sym	Class	Transaction	%	Value $	* Price $	Shares	Shares After	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.